Description
Secukinumab 150 mg
Evitar su uso durante el embarazo y la lactancia
PRINCIPIO ACTIVO: BETAMETASONA FOSFATO DISODICO Y DIPROPIONATO
Caja con 30 tabletas de liberación prolongada de 9 mg
Puede requerirse dosis adicional en casos graves
BRONCOMED JBE. CAJA C/FCO. C/120 ML. AC ACETILSALICILICO Secukinumab 150 mgSUSTANCIA: BRONCOMED JBE. CAJA C FCO. C 120 ML. FABRICANTE: LIOMONT
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
